Thornburg Investment Management Inc Nevro Corp Transaction History

Thornburg Investment Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$141.6 - $179.06 $470,253 - $594,658	-3,321 Reduced 4.79%	66,042 $10.9 Million
Q1 2021 May 14, 2021	SELL	$132.81 - $182.18 $12.3 Million - $16.9 Million	-92,591 Reduced 57.17%	69,363 $9.68 Million
Q4 2020 Feb 09, 2021	BUY	$138.17 - $184.34 $22.4 Million - $29.9 Million	161,954 New	161,954 $28 Million
Q1 2019 May 07, 2019	SELL	$35.52 - $62.62 $7.32 Million - $12.9 Million	-206,053 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$35.43 - $56.29 $35 - $56	1 Added 0.0%	206,053 $8.01 Million
Q3 2018 Nov 02, 2018	BUY	$44.22 - $75.47 $1.23 Million - $2.1 Million	27,765 Added 15.57%	206,052 $11.7 Million
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $1.31 Million - $1.67 Million	-18,056 Reduced 9.2%	178,287 $14.2 Million
Q1 2018 May 07, 2018	BUY	$69.46 - $88.57 $106,968 - $136,397	1,540 Added 0.79%	196,343 $17 Million
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $1.26 Million - $1.79 Million	-19,146 Reduced 8.95%	194,803 $13.4 Million
Q3 2017 Nov 13, 2017	SELL	$80.87 - $91.08 $2.87 Million - $3.24 Million	-35,521 Reduced 14.24%	213,949 $19.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	249,470	249,470 $18.6 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Thornburg Investment Management Inc with notifications on news.